Rhee, Connie M.
Zhou, Meijiao
Woznick, Rachael
Mullon, Claudy
Anger, Michael S.
Ficociello, Linda H. http://orcid.org/0000-0003-3523-0028
Funding for this research was provided by:
Fresenius Medical Care Renal Therapies Group
Article History
Received: 19 January 2022
Accepted: 25 July 2022
First Online: 11 August 2022
Declarations
:
: MZ, RW, CM, MSA, and LHF are employees of Fresenius Medical Care. CM and MSA own stock in Fresenius Medical Care AG & Co. KGaA. CMR has received honoraria and/or support from Ardelyx, AstraZeneca, Dexcom Inc., Fresenius, Nutricia, Reata, and Roche.
: There was no recruitment of subjects in this study. It was a retrospective database analysis using de-identified existing data records. This study was reviewed by New England Independent Review Board (NEIRB) and determined to be exempted under the Common Rule and applicable guidance (NEIRB Work Order #: 1–10085-1; Sponsor Protocol #: EBM 2019 003). We adhered to the Declaration of Helsinki; informed consent was not required.